Cardiomyopathy, Restrictive
"Cardiomyopathy, Restrictive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.
Concept/Terms
Cardiomyopathy, Restrictive- Cardiomyopathy, Restrictive
- Cardiomyopathies, Restrictive
- Restrictive Cardiomyopathies
- Restrictive Cardiomyopathy
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Restrictive".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Restrictive".
This graph shows the total number of publications written about "Cardiomyopathy, Restrictive" by people in Harvard Catalyst Profiles by year, and whether "Cardiomyopathy, Restrictive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Cardiomyopathy, Restrictive" by people in Profiles.
-
Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association. Circulation. 2023 07 11; 148(2):174-195.
-
Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery. Cell Rep Med. 2023 03 21; 4(3):100976.
-
Sex-Related Differences in Genetic Cardiomyopathies. J Am Heart Assoc. 2022 05 03; 11(9):e024947.
-
Outcomes after heart transplantation in patients with cardiac sarcoidosis. ESC Heart Fail. 2022 04; 9(2):1167-1174.
-
Left Ventricular Assist Device Implantation in Hypertrophic and Restrictive Cardiomyopathy: A Systematic Review. ASAIO J. 2021 03 01; 67(3):239-244.
-
Response by Ma et al to Letter Regarding Article, "Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy". Circ Genom Precis Med. 2018 04; 11(4):e002140.
-
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2018 03 13; 71(10):1130-1148.
-
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series. J Am Coll Cardiol. 2018 03 13; 71(10):1149-1166.
-
Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy. Circ Cardiovasc Genet. 2017 Dec; 10(6).
-
Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier? Amyloid. 2017 Dec; 24(4):226-230.